Endpoints News6m
No­vo Nordisk looks in­to start­ing GLP-1 drug tri­als for ad­dic­tion
Novo Nordisk considers exploring GLP-1 drugs like semaglutide for addiction treatment, following Eli Lilly's interest.
Novo to test if GLP-1 weight loss drugs can help curb addiction
Novo Nordisk (NVO) plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with ...